Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01933295 · ClinicalTrials.gov registry record · NA
Behavioral Treatment of Menopausal Insomnia; Sleep and Daytime Outcomes
A NA study of Menopause, sponsored by Christopher Drake.
- Completed
- Registry status
- NA
- Development phase
- 154
- Enrollment target
- 1
- Study location
NCT01933295 is a NA study of Menopause that has completed, run by Christopher Drake. The registered enrollment target is 154 participants, below the 9,391-participant average among 54 other Menopause trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01933295, a NA study of Menopause, has completed, sponsored by Christopher Drake.
- COMPLETED
- Registry status
- NA
- Development phase
- 154 participants
- Enrollment target
- 1
- Study location
Study Summary
Insomnia is recognized as the most prevalent and "costly" sleep disorders and is associated with considerable morbidity including significantly reduced quality of life, impaired work performance, and increased risk for major depressive disorder.1-4 Insomnia is a key symptom of the menopausal transition. Cognitive-behavioral therapy for insomnia (CBT-I) yields equivalent short-term efficacy and superior long-term durability to pharmacological treatment of insomnia. The efficacy of cognitive behavioral therapy for insomnia comorbid with menopause will be tested.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy for Insomnia
- BEHAVIORAL Sleep Restriction Therapy
- BEHAVIORAL Sleep Education
Study Locations (1)
Michigan
- Henry Ford Hospital - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2014-03-01 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01933295
The ClinicalTrials.gov registry entry for NCT01933295 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,391-participant average among 54 other Menopause trials with a reported enrollment target (98% lower). The listed sponsor is Christopher Drake, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Menopause appearing as the primary indexed condition, and to 3 interventions - of which Cognitive Behavioral Therapy for Insomnia is the first listed.
NCT01933295 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT01933295 about?
NCT01933295 is a clinical study titled "Behavioral Treatment of Menopausal Insomnia; Sleep and Daytime Outcomes". Insomnia is recognized as the most prevalent and "costly" sleep disorders and is associated with considerable morbidity including significantly reduced quality of life, impaired work performance, and increased risk for major depressive disorder.1-4 Insomnia is a key symptom of the menopausal transit...
What is the current status of trial NCT01933295?
This trial is currently completed. It is a NA study. The enrollment target is 154 participants. The study started on 2014-03-01. Estimated completion is 2018-12-31.
What conditions does trial NCT01933295 study?
This clinical trial studies the following conditions: Menopause.
What interventions are being tested in trial NCT01933295?
The interventions under investigation include: Cognitive Behavioral Therapy for Insomnia (BEHAVIORAL), Sleep Restriction Therapy (BEHAVIORAL), Sleep Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01933295?
This trial is sponsored by Christopher Drake, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01933295 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Menopause
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Hot Flashes and Neurovascular Function in Women
RECRUITING · NA
-
Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, Parallel, Placebo-controlled Study
RECRUITING · NA
-
Improving Sympathetic Activity, Hot Flashes, and Sleep in Midlife Women Using Inspiratory Muscle Strength Training
RECRUITING · NA
-
Exercise Training Intensity and Nitrate Supplementation in Post-Menopausal Females
RECRUITING · NA
-
Depression, Aging, Stress and Heart Health Study
RECRUITING · NA
-
Choline Dose Ranging in Postmenopausal Women
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.